---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-008576"
form_type: "8-K"
ticker: "IVF"
cik: "0001417926"
company_name: "INVO Fertility, Inc."
filed_at: "2024-03-01T23:59:59+00:00"
generated_at: "2026-06-05T05:23:54.718388+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# INVO Bioscience sells $344,925 of future receipts for $236,250; net proceeds $225,000

## Summary
- Net proceeds of $225,000 from sale of future receipts; total repayment amount is $344,925.
- Weekly payments of $13,797 due until purchase price is fully repaid.
- Proceeds to be used for working capital and general corporate purposes.
- Transaction structured as a purchase and sale of future receipts, not a traditional loan.

## SEC filing metadata
- accession: 0001493152-24-008576
- form_type: 8-K
- ticker: IVF
- cik: 0001417926
- company_name: INVO Fertility, Inc.
- filed_at: 2024-03-01T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1417926/000149315224008576/0001493152-24-008576-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1417926/000149315224008576/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-008576
- JSON: https://secwatch.observer/filing/0001493152-24-008576.json
- Plain text: https://secwatch.observer/filing/0001493152-24-008576.txt

## Key facts
- Debt Financings
  INVO Fertility, Inc. incurred debt of $344,925 with Buyer maturing Until the purchase price has been repaid.
  - Principal: $344,925
  - Counterparty: Buyer
  - Maturity: Until the purchase price has been repaid
  - Event: incurrence
  source text: On February 26, 2024, INVO Bioscience, Inc. (the “Company”) finalized an Agreement for the Purchase and Sale of Future Receipts (the “Future Receipts Agreement”) with a buyer (the “Buyer”) under which the Buyer purchased $344,925 of our future sales for a gross purchase price of $236,250.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1417926/000149315224008576/0001493152-24-008576-index.htm
- Material Agreements
  INVO Fertility, Inc. entered into Agreement for the Purchase and Sale of Future Receipts with Buyer valued at $236,250 (effective 2024-02-26).
  - Action: entry
  - Agreement: asset purchase
  - Counterparty: Buyer
  - Value: $236,250
  - Effective: 2024-02-26
  source text: On February 26, 2024, INVO Bioscience, Inc. (the “Company”) finalized an Agreement for the Purchase and Sale of Future Receipts (the “Future Receipts Agreement”) with a buyer (the “Buyer”) under which the Buyer purchased $344,925 of our future sales for a gross purchase price of $236,250.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1417926/000149315224008576/0001493152-24-008576-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.